Skin Cancer
Infiltrative trichilemmal carcinoma treated with 5% imiquimod cream
Published in Clinical Oncology Week, September 12th, 2005
"TLC is a rare cutaneous neoplasm that occurs in the sun-exposed skin of the elderly. Although the clinical behavior of TLC appears to be relatively indolent, wide excision or Mohs micrographic surgery is the recommended treatment owing to its locally aggressive growth," scientists in Korea reported.
"Recently, imiquimod has become an important part of the armamentarium in the treatment of nonmelanoma skin cancer. This article serves to remind dermatologists that in addition to Mohs micrographic surgery and surgical excision, imiquimod 5% cream may have a role in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Gastrectomy
Preoperative imaging of surrounding arteries by 3D-CT aided gastrectomy studied - Lung Cancer
Oxygen-enhanced MR imaging correlated with postsurgical lung function - Adenocarcinoma
Outcome of surgical treatment for early esophageal adenocarcinoma revealed - Adenomas
Adenoma with gastric differentiation reported - Analgesia
Future role of anesthesiologists in pain management studied - Angiosarcoma
Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
